Literature DB >> 2345080

Extravascular extravasation of radiographic contrast media. Effects of conventional and low-osmolar agents in the rat thigh.

R H Cohan1, R A Leder, D Bolick, A J Herzberg, L W Hedlund, C T Wheeler, M J Helms, N R Dunnick.   

Abstract

We compared the damage resulting from intradermal injection of four commonly used radiographic contrast media in laboratory rats. Sixty percent meglumine diatrizoate (Reno M 60) and ioxaglate (Hexabrix) produced significantly more ulceration and crusting on gross inspection and more necrosis, edema, and hemorrhage on histologic evaluation than iopamidol 300 (Isovue) or 0.9% (normal) saline. Thirty percent meglumine diatrizoate (Reno M Dip) had an intermediate toxicity, resulting in significantly more visible swelling and more microscopically detected hemorrhage than iopamidol or saline, but less ulceration/crusting and necrosis than Reno M 60 and ioxaglate. Since the three contrast agents of similar osmolality produced different degrees of tissue damage, our results suggest that factors other than high osmolality are partially responsible for determining the severity of injuries from extravasated contrast media.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2345080     DOI: 10.1097/00004424-199005000-00006

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  3 in total

1.  Computed tomography contrast media extravasation: treatment algorithm and immediate treatment by squeezing with multiple slit incisions.

Authors:  Sue Min Kim; Kyung Hoon Cook; Il Jae Lee; Dong Ha Park; Myong Chul Park
Journal:  Int Wound J       Date:  2016-07-19       Impact factor: 3.315

2.  [Acute compartment syndrome of the forearm after paravasation of contrast medium. Case report].

Authors:  F Ensat; M Babl; M Spies
Journal:  Radiologe       Date:  2010-03       Impact factor: 0.635

3.  [Development of compartment syndrome after intravenous administration of an X-ray contrast medium. Recommendations on acute therapy regimens].

Authors:  N Hawi; M Citak; E Liodakis; M Petri; C Haasper; C Krettek; R Meller
Journal:  Unfallchirurg       Date:  2014-04       Impact factor: 1.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.